Pharma

Your Article Summary

See Latest Articles

Astellas launches lexiscan (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (mpi)
Astellas, 09/11/09

Astellas Pharma US, Inc. announced the commercial availability of Lexiscan injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress agent in radionuclide MPI a test that detects and characterizes coronary artery disease in patients unable to undergo adequate exercise stress. Lexiscan, co–developed with CV Therapeutics, is the first A2A adenosine receptor agonist shown to be safe and effective as a pharmacologic stress agent in MPI studies.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09

 See all of Medical Devices/Products